Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Objective Recent studies have provided variable information on the frequency and context of diversion and the use of nonprescribed and prescribed stimulant medications in adolescent and young adult populations. The purpose of this systematic review of the literature is to evaluate the extent and characteristics of stimulant misuse and diversion in attention-deficit/hyperactivity disorder (ADHD) and non-ADHD individuals. Method We conducted a systematic review of the literature of available studies looking at misuse and diversion of prescription ADHD medications using misuse, diversion, stimulants, illicit use, and ADHD medications as key words for the search. Results We identified 21 studies representing 113,104 subjects. The studies reported rates of past year nonprescribed stimulant use to range from 5% to 9% in grade school- and high school-age children and 5% to 35% in college-age individuals. Lifetime rates of diversion ranged from 16% to 29% of students with stimulant prescriptions asked to give, sell, or trade their medications. Recent work suggests that whites, members of fraternities and sororities, individuals with lower grade point averages, use of immediate-release compared to extended-release preparations, and individuals who report ADHD symptoms are at highest risk for misusing and diverting stimulants. Reported reasons for use, misuse, and diversion of stimulants include to concentrate, improve alertness, "get high," or to experiment. Conclusions The literature…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and there have been reports of abuse and misuse of stimulant ADHD medication (Kollins, MacDonald, & Rush, 2001; Wilens et al., 2008).”
From Stimulant ADHD medication and risk for substance abuse (2014) · cites this paper as Wilens et al., 2008
In the citing paper
“substantial data indicate that a minority of patients with ADHD divert their stimulant medication for misuse byothers 176 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [176]
In the citing paper
“Given the burden of attention, behavioural and cognitive deficits often noted in children with ADHD and concerns about over prescription of medications with side effects [116], exercise could hold promise as an adjunctive treatment and requires testing in robust well-powered RCTs.”
From Exercise as Medicine for Mental and Substance Use Disorders: A Meta-review of the Benefits for Neuropsychiatric and Cognitive Outcomes (2020) · cites this paper as [116]
In the citing paper
“Long-acting preparations improve compliance and may decrease the potential for abuse, misuse, or recreational use.”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
In the citing paper
“the long-acting formulations are associated with a lower abuse potential compared with the shorter acting formulations”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Self-citation(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
The Worldwide prevalence of ADHD: is it an American condition?
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1,516
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
General hospital psychiatry: the Italian experience.
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Europe PMC (PubMed Central) · Cited by 1,317
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Cited by
Items 301–400 of 823
Waes, V. V., Vandrevala, M., Beverley, J. A., & Steiner, H. (2013) · Addiction Biology · doi:10.1111/adb.12067 · Cited by 19
“The addiction liability of methylphenidate alone is more limited compared with illicit psychostimulants (Svetlov, Kobeissy & Gold 2007), and it remains unclear whether proper medical use of drugs such as methylphenidate (low oral doses) has detrimental effects (Kollins 2008; Wilens et al. 2008).”
BackgroundInfluentialPharmacological Neuroenhancement: Substances and Epidemiology
Franke, A. G., & Lieb, K. (2013) · Trends in augmentation of human performance · doi:10.1007/978-94-007-6253-4_2 · Cited by 23
Park, T. M., & Haning, W. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.02.004 · Cited by 22
Physician Perceptions of ADHD Stimulant Diversion and Misuse
Colaneri, N., Keim, S. A., & ADESMAN, A. R. (2016) · Journal of Attention Disorders · doi:10.1177/1087054716649664 · Cited by 21
In search of optimal psychoactivation: stimulants as cognitive performance enhancers
Rozenek, E. B., Górska, M., Wilczyńska, K., & Waszkiewicz, N. (2019) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/aiht-2019-70-3298 · Cited by 20
Sattler, S., Mehlkop, G., Bahr, V., & Betsch, C. (2021) · Journal of Drug Issues · doi:10.1177/0022042621994547 · Cited by 19
“…better understand this underexplored phenomenon since prior research indicates a covariation with parenting and/or CE drug use (willingness) (Borra & Sevilla, 2019; Láng, 2018; Sattler & Wiegel, 2013; Substance Abuse and Mental Health Services Administration, 2019; Wall, 2010; Wilens et al., 2008).”
BackgroundPsychiatric Medication-Seeking Beliefs and Behaviors among College Students
Stone, A. M., & Merlo, L. J. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.643992 · Cited by 19
Pre-Incarceration Rates of Nonmedical Use of Prescription Drugs among Black Men from Urban Counties
Wheeler, P. B., Stevens-Watkins, D. J., Knighton, J.-S., Mahaffey, C. C., & Lewis, D. (2018) · Journal of Urban Health · doi:10.1007/s11524-018-0258-2 · Cited by 19
Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
Najib, J., Wimer, D., Zeng, J., Lam, K. W., Romanyak, N., Paige Morgan, E., & Thadavila, A. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517728090 · Cited by 19
Nicotine and the developing brain: Insights from preclinical models
McCarthy, D. M., Zhang, L., Wilkes, B. J., Vaillancourt, D. E., Biederman, J., & Bhide, P. G. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173355 · Cited by 22
Alzoubi, A., Nasor, E. M., Suliman, E. M., Alqaderi, N., Abbastanira, S. H. I., Abdi, S. A. H., Mustafa, S., & Kheirallah, K. A. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s405279 · Cited by 25
Beverley, J. A., Piekarski, C., Waes, V. V., & Steiner, H. (2014) · Basal Ganglia · doi:10.1016/j.baga.2014.10.001 · Cited by 18
“There is also increasing abuse of such medical psychostimulants as “cognitive enhancers” by healthy children and adults [2,4,5].”
BackgroundMethodPeña, I. D., Lee, J. C., Lee, H. L., Woo, T. S., Lee, H. C., Sohn, A. R., & Cheong, J. H. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.090 · Cited by 18
Peña, I. D., Gonzales, E. L., de la Peña, J. B., Kim, B.-N., Han, D. H., Shin, C. Y., & Cheong, J. H. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.08.019 · Cited by 21
Marchei, E., Farré, M., Lozano, R. P., García‐Algar, Ó., Pellegrini, M., Pacifici, R., & Pichini, S. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181e4e6f8 · Cited by 17
Koblan, K. S., Hopkins, S. C., Sarma, K., Gallina, N. B., Jin, F., Levy‐Cooperman, N., Schoedel, K. A., & Loebel, A. D. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.029 · Cited by 19
Peer influence as a potential magnifier of ADHD diagnosis
Aronson, B. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.09.010 · Cited by 20
Differentiating motives for nonmedical prescription stimulant use by personality characteristics
Thiel, A. M., Kilwein, T. M., Young, K. P. D., & Looby, A. R. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.040 · Cited by 20
Manor, I., Newcorn, J. H., Faraone, S. V., Adler, L. A., & The Metadoxine Study Group (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2689 · Cited by 18
Self-citationLoskutova, N., Waterman, J., Callen, E. F., Staton, E. W., Bullard, E., & Shields, J. B. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.01.190071 · Cited by 16
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
Stockman, J. A. (2009) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)79016-x · Cited by 17
Time to address stimulant abuse on our campuses
Rosenfield, D., Hébert, P. C., Stanbrook, M. B., the editorial advisory team, Flegel, K., & MacDonald, N. E. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.111149 · Cited by 21
Shopping behavior for ADHD drugs: results of a cohort study in a pharmacy database
Cepeda, M. S., Fife, D., Berwaerts, J., Yuan, Y., & Mastrogiovanni, G. (2014) · Drugs in R&D · doi:10.1007/s40268-014-0058-4 · Cited by 17
“The non-medical use of ADHD medications in high-school-age children in the US is estimated at around 9 %, and in college-age individuals goes from 5 to 35 % [1].”
BackgroundThe beginning of the end of prohibition: the politics of drug addiction
Luty, J. S. (2016) · BJPsych Advances · doi:10.1192/apt.bp.115.014704 · Cited by 18
“Wilens et al (2008) reviewed 21 studies (involving over 100 000 children and adolescents) assessing the diversion and misuse of stimulants prescribed for attention-deficit hyperactivity disorder (primarily methylphenidate).”
BackgroundManor, I., Rubin, J. S., Daniely, Y., & Adler, L. A. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2795 · Cited by 18
Self-citationRasmussen, L., Zoëga, H., Hallas, J., & Pottegård, A. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3852 · Cited by 16
Trends in drug substances detected in illegal weight-loss medicines and dietary supplements
Venhuis, B. J., Zwaagstra, M. E., Berg, J., Wagenaar, H., van Riel, A. J. H. P., & Barends, D. M. (2009) · Cited by 16
Alter, D., Beverley, J. A., Patel, R., Bolaños‐Guzmán, C. A., & Steiner, H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117715598 · Cited by 16
Zhang, L., McCarthy, D. M., Jaunarajs, K. L. E., Biederman, J., Spencer, T. J., & Bhide, P. G. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa238 · Cited by 17
Soeiro, T., Frauger, É., Pradel, V., & Micallef, J. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12612 · Cited by 18
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Boesen, K., Paludan‐Müller, A. S., Gøtzsche, P. C., & Jørgensen, K. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857.pub2 · Cited by 38
Pilot Study of Droxidopa With Carbidopa in Adults With ADHD
Adler, L. A., & Gorny, S. W. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715580393 · Cited by 18
Self-citationSokhadze, E. M., Stewart, C., Tasman, A., Daniels, R., & Trudeau, D. L. (2011) · Journal of Neurotherapy · doi:10.1080/10874208.2011.595298 · Cited by 17
Guzick, A. G., McNamara, J. P. H., Reid, A. M., Balkhi, A. M., Storch, E. A., Murphy, T. K., Goodman, W. K., Bussing, R., & Geffken, G. R. (2016) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2016.11.004 · Cited by 20
Markotić, F., Jurisic, D., Ćurković, M., Puljiz, M., Novinscak, M., Bonassin, K., Vrdoljak, D., Vojvodić, Ž., Hajdarović, S. P., Pekez-Pavliško, T., et al. (2017) · European Journal of Pain · doi:10.1002/ejp.1157 · Cited by 18
“According to our current knowledge, analgesics are amongst the most commonly shared prescription medications (Petersen et al., 2008; Wilens et al., 2008; Ward et al., 2011; Beyene et al., 2014).”
BackgroundResultInfluentialPsychopharmacology for children: From off label use to registration
Wohlfarth, T. D., Kalverdijk, L. J., Rademaker, C. M. A., Schothorst, P. F., Minderaa, R. B., & Wied, C. C. G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.04.007 · Cited by 16
“, 2008; Langendijk and Wilde, 2006), and about psychosis (Ross, 2006) and dependence (Wilens et al., 2008).”
BackgroundAutomedicação de psicofármacos entre estudantes universitários de odontologia e medicina
Araújo, A. F. L. L., Ribeiro, M. C., & Vanderlei, A. D. (2021) · Revista Internacional de Educação Superior · doi:10.20396/riesup.v7i0.8659934 · Cited by 38
Prescription Stimulant Misuse and Diversion Events Among College Students: A Qualitative Study
Garcia, C., Valencia, B., Roldan, K. D., Garcia, J., Ayala, J. A., Looby, A. R., McMullen, J. M., & Bavarian, N. (2021) · Journal of Prevention · doi:10.1007/s10935-021-00654-z · Cited by 29
“As demonstrated by past research, misuse and diversion were not limited to students with a prescription (Wilens et al., 2008).”
BackgroundExploring the use of cognitive enhancement substances among Portuguese university students
Cavaco, A. M. D. N., Ribeiro, J., & Nørgaard, L. S. (2021) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2021.100097 · Cited by 20
“Although nonmedical use of PCE substances may affect a larger population,(5,14) university and college students are two specific subpopulations especially noted to use PCE substances (up to 17%, on average).(11,15) DeSantis et al.”
BackgroundMalingering and Stimulant Medications Abuse, Misuse and Diversion
Sadek, J. R. (2022) · Brain Sciences · doi:10.3390/brainsci12081004 · Cited by 16
“One study suggested that lifetime rates of stimulant diversion among college students ranges from 15% to 30% [14].”
BackgroundO uso não prescrito de metilfenidato entre acadêmicos de Medicina
Carneiro, S. G., Prado, A. S. T., Araujo, E. C. D. J., Moura, H. C., Strapasson, J. F., Rabelo, N. F., & Ribeiro, T. T. (2013) · Cadernos UniFOA · Cited by 57
Outcomes and Predictors of Stimulant Misuse in College Students with and Without ADHD
Francis, A. R., Weyandt, L. L., Anastopoulos, A. D., DuPaul, G. J., & Shepard, E. (2021) · Journal of Attention Disorders · doi:10.1177/10870547211027650 · Cited by 34
Lord, S., & Marsch, L. A. (2005) · American Academy of Pediatrics eBooks · doi:10.1542/9781581107258-ch15 · Cited by 18
Dextromethorphan Abuse and Dependence in Adolescents
Akerman, S. C., Hammel, J. L., & Brunette, M. F. (2010) · Journal of Dual Diagnosis · doi:10.1080/15504263.2010.537515 · Cited by 15
“Clinicians should avoid prescribing potentially abusable medications, such as stimulants and benzodiazepines, in this population, due to the high potential for abuse and diversion (Garnier et al., 2010; Wilens et al., 2008).”
BackgroundGhosh, M., Holman, C. D. J., & Preen, D. B. (2014) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12269 · Cited by 15
“Characteristics No ADHD (%) ADHD (%) Participants 657,676 13,555 Mean Age in Years (SD) 13 (5) Sex”
BackgroundPeña, I. D., de la Peña, J. B., Kim, B.-N., Han, D. H., Noh, M., & Cheong, J. H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0470-x · Cited by 18
“However, the use of psychostimulants for the treatment of ADHD has been considered a controversial practice (Kollins 2008a; Wilens et al. 2008).”
Marusich, J. A., McCuddy, W. T., Beckmann, J. S., Gipson, C. D., & Bardo, M. T. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32834d623e · Cited by 18
Non-medical prescription stimulant use: Investigating modifiable risk factors
Looby, A. R., Beyer, D. L., & Zimmerman, L. M. (2014) · Addiction Research & Theory · doi:10.3109/16066359.2014.946411 · Cited by 17
“For example, Wilens et al. (2008) found that up to 35% of college students reported NPS in the past year, and Looby, De Young, and Earleywine (2013) found a 19% past-6-month incidence rate of NPS among at-risk college students.”
BackgroundLooby, A. R., Kassman, K. T., & Earleywine, M. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.03.012 · Cited by 17
Consuming an edge: ADHD, stimulant use, and psy culture at the corporate university
Levinson, J., & McKinney, K. A. (2013) · Transcultural Psychiatry · doi:10.1177/1363461513490720 · Cited by 17
“A review of studies from Canada and the USA determined that between 5% and 35% of college students had taken stimulants for nonmedical purposes in the last year (Wilens et al., 2008).”
BackgroundInfluentialCummins, E. D., Griffin, S. B., Duty, C. M., Peterson, D. J., Burgess, K. C., & Brown, R. W. (2014) · Developmental Neuroscience · doi:10.1159/000360636 · Cited by 15
Dahlman, D., Abrahamsson, T., Kral, A. H., & Håkansson, A. (2016) · Journal of Addiction · doi:10.1155/2016/9298571 · Cited by 16
“Nonmedical use of prescription stimulants is described in various subpopulations such as high school and college students in the US [11, 50, 51] and also among people with substance disorders [15, 52].”
BackgroundPredictors of Prescription Stimulant Misuse in U.S. College Graduates
Holt, L. J., & McCarthy, M. D. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1692867 · Cited by 13
“Participants selected all of the ways they obtained prescription stimulants in college: obtained from a prescriber; given by a friend/relative for free; bought from friend/relative; took from friend/relative without their knowledge; bought from dealer/stranger; traded another drug for a prescription stimulant; stole i…”
BackgroundPsychosocial Interventions for College Students with ADHD: Current Status and Future Directions
Vasko, J. M., Oddo, L. E., Meinzer, M. C., Garner, A. M., & Chronis-Tuscano, A. M. (2020) · The ADHD Report · doi:10.1521/adhd.2020.28.4.5 · Cited by 18
Bonati, M. R., Scarpellini, F., Cartabia, M., Zanetti, M., & on behalf of the Lombardy ADHD Group (2021) · Children · doi:10.3390/children8070598 · Cited by 12
“The stimulant medications for ADHD are more effective than non-stimulant medications but are also more likely to be diverted, misused, and abused [13,14].”
BackgroundFranke, A. G., Roser, P., Lieb, K., Vollmann, J., & Schildmann, J. (2016) · Substance Use & Misuse · doi:10.1080/10826084.2016.1200619 · Cited by 17
“…Bonertz, et al., 2011; Franke, Christmann, et al., 2011; Kudlow et al., 2013; Teter, McCabe, Cranford, Boyd, & Guthrie, 2005; Webb et al., 2013; Wilens et al., 2008), and there is real hype in the world of public media that has been examined by Partridge, Bell, Lucke, Yeates, and Hall (2011).”
BackgroundResultBlunted Frontostriatal Blood Oxygen Level–Dependent Signals Predict Stimulant and Marijuana Use
Blair, M. A., Stewart, J. L., May, A. C., Reske, M., Tapert, S. F., & Paulus, M. P. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.03.005 · Cited by 17
“4% and 5% to 35% of college students endorsing cocaine (1) and recreational amphetamine (methylphenidate, dextroamphetamine) (2) use, respectively, and 16% of cocaine experimenters developing dependence within 10 years (3).”
BackgroundGrimsrud, M. M., Brekke, M., Syse, V. L., & Vallersnes, O. M. (2019) · BMC Emergency Medicine · doi:10.1186/s12873-019-0271-0 · Cited by 20
King, N., Floren, S., Kharas, N., Thomas, M., & Dafny, N. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172737 · Cited by 13
A Temporal Cognitive Model of the Influence of Methylphenidate (Ritalin) on Test Anxiety
Lelieveld, I. S., Storre, G.-J., & Ziabari, S. S. M. (2020) · Advances in intelligent systems and computing · doi:10.1007/978-981-32-9343-4_26 · Cited by 13
Lamoureux, L., Beverley, J. A., Marinelli, M., & Steiner, H. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100131 · Cited by 12
“Unintended co-exposure thus occurs in patients taking SSRIs who use MP recreationally or as a cognitive enhancer [4,20].”
BackgroundReflections on Neuroenhancement
Glannon, W. (2014) · Springer eBooks · doi:10.1007/978-94-007-4707-4_93 · Cited by 13
Lee, M. J., Yang, P. B., Wilcox, V. T., Burau, K. D., Swann, A. C., & Dafny, N. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0510-8 · Cited by 13
“There is currently no universally accepted MPD dose guideline used to achieve optimal blood levels for the treatment of ADHD patients (Gadow 1997; Gatley et al. 1999; Pelham et al. 2001; Wilens et al. 2008 ).”
MethodWestover, A. N., Nakonezny, P. A., Halm, E. A., & Adinoff, B. H. (2017) · Addiction · doi:10.1111/add.14122 · Cited by 14
ADHD in Children: Common Questions and Answers.
Chang, J. G., Cimino, F. M., & Gossa, W. (2020) · American family physician · Cited by 21
Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors
Brumboiu, I., Porrovecchio, A., Pezé, T., Hurdiel, R., Iaru, I., Mogoșan, C., Ladner, J., & Tavolacci, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18083880 · Cited by 24
“The promotion of wakefulness was also reported by university students as one of the main reasons for neuroenhancement [36].”
BackgroundMolina, B. S. G., Joseph, H. M., Kipp, H., Lindstrom, R. A., Pedersen, S. L., Kolko, D. J., Bauer, D. J., & Subramaniam, G. (2021) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000923 · Cited by 13
“Up to 24% of teens with stimulant prescriptions for ADHD have reported diverting (selling, sharing, or trading) their medication, although the rates are highly variable across studies.(5,8,9) Unfortunately, very little is known about adolescent stimulant diversion and the demographic, psychosocial, and treatment risk…”
BackgroundTomažič, T., & Čelofiga, A. K. (2022) · Healthcare · doi:10.3390/healthcare10060972 · Cited by 13
Prävalenz und Therapie bei Abhängigkeit von Methamphetamin („Crystal“)
Soyka, M., Koller, G., Proebstl, L., Kamp, F., Franke, A. G., Schmidt, P., Baumgärtner, G., Schacht-Jablonowsky, M., Sievert, A., Straif, M., et al. (2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0042-119862 · Cited by 16
Beyond the pill: new medication delivery options for ADHD
Cutler, A. J., & Mattingly, G. W. (2017) · CNS Spectrums · doi:10.1017/s1092852916000936 · Cited by 14
“Long-acting stimulants are associated with lower rates of misuse or abuse than their short-acting counterparts because their use does not correlate as strongly with euphoria and it is more difficult to extract active drug ingredients.(83,87,88) Several long-acting alternative formulations of stimulants have recently b…”
BackgroundLaCount, P. A., Hartung, C. M., Canu, W. H., & Knouse, L. E. (2018) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2018.1518120 · Cited by 17
“, 2009), and they carry risk for misuse and diversion—namely, among college students without ADHD (Wilens et al., 2008).”
BackgroundResultVogel, M., Bucher, P., Strasser, J., Liechti, M. E., Krähenbühl, S., & Dürsteler, K. M. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1130883 · Cited by 15
“Diversion and misuse, particularly by subjects with polysubstance use disorders, have been described frequently (Bruggisser, Bodmer, and Liechti 2012; Wilens et al. 2008).”
BackgroundBenival, D. M., Rana, D., & Salave, S. (2021) · Current Drug Delivery · doi:10.2174/1567201818666211208101035 · Cited by 12
McGuier, E. A., Kolko, D. J., Pedersen, S. L., Kipp, H., Joseph, H. M., Lindstrom, R. A., Bauer, D. J., Subramaniam, G., & Molina, B. S. G. (2022) · Prevention Science · doi:10.1007/s11121-022-01411-2 · Cited by 13
“Nonmedical use of stimulant medications intended for treatment of ADHD is a significant problem (Faraone et al., 2020; McCabe & West, 2013; McCabe et al., 2014; Wilens et al., 2008).”
BackgroundTranscranial Stimulation for the Treatment of Stimulant Use Disorder
Edinoff, A. N., Sall, S., Roberts, T. D., Tomlinson, H., Soileau, L. G., Jackson, E. D., Murnane, K. S., Wenger, D. M., Cornett, E. M., Toms, J., et al. (2023) · Neurology International · doi:10.3390/neurolint15010021 · Cited by 16
“While prescription stimulants have been proven to be an effective treatment option for Attention Deficit Hyperactive Disorder (ADHD), legitimate concerns have come with studies showing high levels of medical misuse, nonmedical use, and stimulant diversion [4].”
BackgroundGender Differences in Cannabis Addiction and Dependence
Davis, C. A., & Fattore, L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_12 · Cited by 13
“Regrettably, however, there has been increasing evidence of the non-medical (ab)use of this drug in schools, universities, and the work place to combat fatigue, improve concentration, and sustain productivity [41].”
BackgroundJain, R., & Stark, J. G. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1218259 · Cited by 13
“Individuals both with and without ADHD misuse stimulant medications; however, the ADHD-patient population may be at an increased risk for stimulant abuse [17].”
BackgroundNouveaux styles de consommation de produits psychoactifs chez les adolescents en France
Jeanne, G., Purper‐Ouakil, D., Rigole, H., & Franc, N. (2016) · L Encéphale · doi:10.1016/j.encep.2016.05.012 · Cited by 12
Vosburg, S. K., Robbins, R. S., Antshel, K. M., Faraone, S. V., & Green, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.631792 · Cited by 10
Bodenburg, S., Wendiggensen, J., & Kasten, E. (2022) · Psychological Injury and Law · doi:10.1007/s12207-022-09448-y · Cited by 13
“The research literature reviewed for this paper found studies examining the abuse of stimulants has increased considerably in the last two decades (Faraone et al., 2020; Fuermaier et al., 2021; Gudmundsdottir et al., 2020; Looby & Earlywine, 2011; Wilens et al., 2008).”
BackgroundDistinguishing Symptoms of ADHD from Other Psychiatric Disorders in the Adult Primary Care Setting
Montano, C. B., & Weisler, R. H. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.05.2287 · Cited by 14
Medical Mimics and Differential Diagnosis in Adult ADHD
Stein, M. A. (2008) · CNS Spectrums · doi:10.1017/s1092852900003278 · Cited by 13
Optimizing Clinical Outcomes Across Domains of Life in Adolescents and Adults With ADHD
Adler, L. A., Mattingly, G. W., Montano, C. B., & Newcorn, J. H. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10063ah1 · Cited by 12
“44 Atomoxetine was not found to be reinforcing in animal self-administration studies, and human studies also suggest low abuse liability.”
Self-citationSpencer, T. J., Bhide, P. G., Zhu, J., Faraone, S. V., Fitzgerald, M., Yule, A. M., Uchida, M., Spencer, A. E., Hall, A. M., Koster, A. J., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11012 · Cited by 16
Pharmacological cognitive enhancement in pediatrics
Colaneri, N., Sheldon, M., & ADESMAN, A. R. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000615 · Cited by 12
“All rights rese in the past year [7], and a more recent study of highschool seniors found a 9.”
BackgroundInfluentialATTENTION DEFICIT HYPERACTIVITY DISORDER AND THE FAMILY COURT
Eme, R. F. (2009) · Family Court Review · doi:10.1111/j.1744-1617.2009.01279.x · Cited by 15
Bell, G. H., Novak, A. J., Griffin, W. C., & Patrick, K. S. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22476 · Cited by 14
Martínez-Raga, J., Knecht, C., de Alvaro, R., Szerman, N., & Ruiz, P. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318277060c · Cited by 16
“K Although psychostimulants in general are considered as first-line pharmacological treatments for adult individuals with a diagnosis of ADHD, long half-life preparations or slowrelease formulations are preferable, particularly in high vulnerability dually diagnosed patients, as these maximize treatment adherence and…”
BackgroundParental perspectives on attention-deficit/hyperactivity disorder treatments for children
Vitulano, L. A., Mitchell, J. T., Vitulano, M. L., Leckman, J. F., Saunders, D. C., Davis, N. O., Woodward, D. W., Goodhue, B., Artukoglu, B. B., & Kober, H. (2022) · Clinical Child Psychology and Psychiatry · doi:10.1177/13591045221108836 · Cited by 16
“However, despite their widespread use and benefits, stimulants also have significant limitations, including side-effects, limited long-term benefits, and the potential for misuse and diversion (Rowland et al., 2002; Wilens et al., 2008).”
BackgroundPerioperative Considerations for Patients Exposed to Psychostimulants
Emerick, T. D., Martin, T. J., & Ririe, D. G. (2023) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006303 · Cited by 16
Contemplating Cognitive Enhancement in Medical Students and Residents
Webb, J., Thomas, J. W., & Valasek, M. A. (2010) · Perspectives in biology and medicine · doi:10.1353/pbm.0.0154 · Cited by 13
“This stands in striking contrast to dozens of studies that have examined stimulant use in college and high school students (Wilens et al. 2008). spring 2010 • volume 53, number 2 209 A long-term and more complex goal will be to investigate why stimulants are thought to be needed, and to find ways…”
BackgroundResultThe Benefits and Limitations of Stimulants in Treating ADHD
Coghill, D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_331 · Cited by 13
Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder
Robinson, C. L., Parker, K., Kataria, S., Downs, E., Supra, R., Kaye, A. D., Viswanath, O., & Urits, I. (2022) · Health Psychology Research · doi:10.52965/001c.38360 · Cited by 16
Vosburg, S. K., Faraone, S. V., Newcorn, J. H., Rostain, A. L., Findling, R. L., Butler, S. F., Dailey-Govoni, T., & Green, J. L. (2020) · Journal of Attention Disorders · doi:10.1177/1087054720943283 · Cited by 11
“These data support previous studies reporting that individuals with and without ADHD use prescription stimulant medications non-medically (Wilens et al., 2008), and extend this consistent misuse firmly to adolescents.”
ResultPrescription Stimulant Misuse and Risk Correlates among Racially-Diverse Urban Adolescents
Goodhines, P. A., Taylor, L. E., Zaso, M. J., Antshel, K. M., & Park, A. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1800740 · Cited by 13
“The past-year assessment timeframe (as opposed to shorter timeframes such as past-month) was chosen due to the low prevalence and infrequent nature of adolescent prescription stimulant misuse (for a review, see Kaye & Darke, 2012; Wilens et al., 2008).”
BackgroundResultMcGuier, E. A., Kolko, D. J., Joseph, H. M., Kipp, H., Lindstrom, R. A., Pedersen, S. L., Subramaniam, G., & Molina, B. S. G. (2021) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.12.006 · Cited by 12
Nasser, A. F., Kosheleff, A. R., Hull, J. T., Liranso, T., Qin, P., Busse, G. D., Fava, M., Maletic, V., Rubin, J. S., & López, F. A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14330 · Cited by 13
Thoër, C., & Robitaille, M. (2013) · Drogues santé et société · doi:10.7202/1013481ar · Cited by 24
McDougall, S. A., Kozanian, O. O., Greenfield, V. Y., Horn, L. R., Gutierrez, A., Mohd‐Yusof, A., & Castellanos, K. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2316-2 · Cited by 13
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Boesen, K., Danborg, P. B., Gøtzsche, P. C., & Jørgensen, K. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857 · Cited by 12
Metadata
- Authors
- WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S.
- Affiliations
- Harvard University (US)
- Corresponding author
- WILENS, TIMOTHY E.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 47
- Issue
- 1
- Pages
- 21-31
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W1970031540
- Cited by
- 824
- References
- 56
- Citations by year
- 2026: 16 · 2025: 44 · 2024: 21 · 2023: 17 · 2022: 26 · 2021: 87 · 2020: 43 · 2019: 50 · 2018: 36 · 2017: 49 · 2016: 60 · 2015: 52 · 2014: 73 · 2013: 49 · 2012: 70
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- the National Institute of Drug Abuse (U10 DA15831 and U10 DA13046)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulant abuse, prescription drug diversion, ADHD medication, adolescents, young adults, university students, risk factors
- MeSH terms
- Adolescent, Adult, Amphetamines, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Methylphenidate, Drug Prescriptions, Self Administration, Illicit Drugs, United States, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.